ShadowBuys

Rep. Daniel Meuser sold Amgen (AMGN)

Rep. Daniel Meuser (R-PA-9) · $1K–$15K · traded Feb 11, 2025

Transaction
Sold
Amount
$1K–$15K
Owner
Spouse
Traded
Feb 11, 2025
Disclosed
Aug 20, 2025
Days to disclose
190 (after the 45-day deadline)
Asset type
Stock
As filed
Amgen Inc. - Common Stock
Industry
Drug Manufacturers - General · Healthcare

Other trades in this filing

  • Sold Microsoft MSFT

    $1K–$15K · Traded Feb 11, 2025 · disclosed Aug 20, 2025 · Spouse · filed 190 days later

    Got $10K from the company’s PAC
  • Sold Visa V

    $15K–$50K · Traded Feb 11, 2025 · disclosed Aug 20, 2025 · Spouse · filed 190 days later

    Committee overlap: Financial ServicesGot $2K from the company’s PAC
  • Sold Aptiv APTV

    $1K–$15K · Traded Feb 11, 2025 · disclosed Aug 20, 2025 · Spouse · filed 190 days later

  • Sold Mondelez International MDLZ

    $1K–$15K · Traded Feb 11, 2025 · disclosed Aug 20, 2025 · Spouse · filed 190 days later

  • Sold Apple AAPL

    $15K–$50K · Traded Feb 11, 2025 · disclosed Aug 20, 2025 · Spouse · filed 190 days later

  • Sold Alphabet GOOGL

    $50K–$100K · Traded Feb 11, 2025 · disclosed Aug 20, 2025 · Spouse · filed 190 days later

  • Sold (partial) NVIDIA NVDA

    $250K–$500K · Traded Feb 11, 2025 · disclosed Aug 20, 2025 · Spouse · filed 190 days later

  • Sold QUALCOMM QCOM

    $15K–$50K · Traded Feb 11, 2025 · disclosed Aug 20, 2025 · Spouse · filed 190 days later

Recent Congress trades in AMGN

Company context for AMGN

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. AMGNContract award·USAspending

    AMGN: Department of Health and Human Services contract award

    NPLATE ADMINISTRATION KIT DEVELOPMENT FOR THE TREATMENT OF APPROVED INDICATIONS, INCLUDING ACUTE RADIATION SYNDROME (ARS)

    First observed: Nov 8, 2026, 9:57 AM ESTEvent / period: Aug 28, 2023Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. AMGNFinancial report·SEC EDGAR

    AMGN: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 3, 2026, 6:37 PM ESTEvent / period: Sep 30, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. AMGNCompany announcement·SEC EDGAR

    AMGN: Financial results

    Filed 8-K for an event or period dated 2026-11-03. Financial results.

    Public: Nov 3, 2026, 4:05 PM ESTEvent / period: Nov 3, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.